News
arGEN-X is awarded €1.3 million IWT Grant to Advance Proprietary SIMPLE Antibody™ Platform for Addressing Challenging Disease Targets
arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B round
Events
IBC’s 22nd Annual International Antibody Engineering and Antibody Therapeutics Conference 4th-8th December, San Diego
www.ibclifesciences.com/antibodyeng/overview.xml